Exelon
Product Images NDC 54868-5954

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Exelon (NDC 54868-5954). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of 4.6 mg Package Label (4.6mg Package Label)

Label for Exelon 4.6mg patch distributed by Physicians Total Care, Inc. The label includes lot number 0000, expiration date 01/00, and states the product is manufactured by LTS Lohmann Therapie-Systeme GmbH & Co. KG, Germany. A barcode with digits 60700300000 is also present.*

FDA Label Image

Image Of 9.5 mg Package Label (9.5mg Package Label)

Label for Exelon 9.5 mg tablet showing distributor as Physicians Total Care, Inc., Tulsa, OK. Includes NDC 54868-5954-0, lot number 000, and expiration date 01/60. A barcode with the number 59540300000 is also visible.*

FDA Label Image

Image Of Figure 1 (Figure 1)

An instructional diagram illustrating the side view of a pill or capsule within a blister pack. It highlights two dimples on the blister layers, indicating structural features with arrows and labeling layers 1 through 5 above and dimples below the pack.*

FDA Label Image

Image Of Figure 2 (Figure 2)

A line graph showing plasma concentration of rivastigmine (ng/mL) over 24 hours. Two dosage groups are represented: 8.5 mg/24 hours and 4.6 mg/24 hours. The y-axis measures rivastigmine concentration, and the x-axis shows time in hours. Data points include error bars indicating variability.*

FDA Label Image

Image Of Figure 3 (Figure 3)

A line graph depicting least square means plus/minus SEM change from baseline ADAS-cog 11 item scores over 24 weeks of treatment. The graph compares clinical improvement or decline among four groups: 17.4 mg/24 hours, 9.5 mg/24 hours, Capsules 6 mg BID, and placebo.*

FDA Label Image

Image Of Figure 4 (Figure 4)

A bar chart illustrating the percentage of patients by ADCS-CGIC rating categories. The chart compares four groups: 17.4 mg/24 hours, 9.5 mg/24 hours, capsules 6 mg BID, and placebo. Categories range from 'Markedly Improved' to 'Markedly Worse,' showing distribution differences among treatment and placebo groups.*

FDA Label Image

Image Of How To Apply (How To Apply)

An instructional illustration showing a hand holding a small packet or sachet next to a pair of scissors cutting along a dotted line on the packet's edge, demonstrating how to open it.*

FDA Label Image

Image Of Where To Apply (Where To Apply)

An anatomical illustration showing gray shaded areas on the front and back of a human torso, highlighting regions on the upper chest and upper back. The diagram appears to indicate application or focus areas on a male figure wearing black briefs, related to the product Exelon.*

FDA Label Image

Image Of Chemical Structure (Chemical Structure)

Chemical structure of Exelon showing the molecular arrangement of its atoms and bonds in a two-dimensional diagram.*

FDA Label Image

Image Of Press Firmly (Press Firmly)

An instructional illustration showing the back of a person with one hand applying or preparing to apply medication or treatment to the upper back area near the shoulder blades. The image appears to depict the placement or application technique related to the product Exelon by Physicians Total Care, Inc.*

FDA Label Image

Image Of Protective Liner (Protective Liner)

Illustration showing a person's hands peeling a translucent protective layer from a round adhesive patch, demonstrating how to prepare the patch for application.*

FDA Label Image

Image Of Sticky Side (Sticky Side)

An instructional illustration showing the application of a patch on the upper back of a person. The person is depicted from behind, with hands placing a rectangular patch on the skin, indicating proper patch placement technique.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.